Thermo Fisher Scientific Inc Stock Prediction and Forecast [TMO]

AI-generated source summary

The analysis of Thermo Fisher Scientific (TMO) stock indicates a mixed outlook. Since late September 2025, the system classifies TMO as hold/accumulate, with a score of 0.770. The stock exceeded expectations, gaining 20.64% in 44 days, averaging 0.47% daily. Short-term is bullish with potential for further gains, and a 3-month trend suggests a 28.79% change, with a possible return ranging from 22.45% to 32.98%. Long-term however, twelve months indicate a potential decline of -0.86%, future price between $384.51 and $597.16. On December 1, 2025, Thermo Fisher Scientific Inc. stock was downgraded to hold/accumulate. On the last trading day, on December 1, the price declined by approximately 1%, trading volume increased to 937,000 shares, risk is very low with weekly volatility of 1.98%. Analyst ratings are neutral, while a sell signal on the three-month Moving Average Convergence Divergence (MACD) suggests close monitoring is advised. It meets resistance at approximately $587.61 and $567.05. On December 1, 2025, the company’s price-to-earnings ratio is 33.67.

AI-generated summary based on the source content.

Evidence and evaluation progress

1. Original source published

   02 Dec 2025, 04:42 UTC

   The analyst published the original source item.

2. First prediction resolved

   05 Jan 2026, 14:30 UTC

   The first evaluable outcome in this case reached a terminal result.

3. Case evaluation completed

   05 Jan 2026, 14:30 UTC

   All evaluable predictions in this case reached terminal outcomes.

4. Source recorded by Tahlil Plus

   18 May 2026, 20:23 UTC

   The public source was preserved as the evidence record for this case.

5. Market predictions extracted

   18 May 2026, 20:47 UTC

   1 eligible signal linked to this case.

6. Outcome tracking started

   02 Jul 2026, 02:14 UTC

   Tahlil Plus began monitoring the extracted predictions.